Literature DB >> 24857082

Radiotherapy for soft tissue sarcoma: 50 years of change and improvement.

Dian Wang1, Ross A Abrams1.   

Abstract

Radiotherapy for soft tissue sarcoma (STS) has advanced significantly over the past 50 years. This review focuses briefly on the period from 1964 to 1999 and more substantially on the changes of the past 15 years, such as IMRT and image-guided radiotherapy (IG-RT), especially when brought together (IG-IMRT) in the same planning and delivery process to treat localized STS. In particular, the introduction of IG-RT, target volume definitions for IG-RT, and review of recent clinical trials using IG-RT to treat localized STS in extremity will be reviewed. Finally, potential investigational agents combined with IG-RT to improve outcomes in patients with localized STS are discussed.

Entities:  

Mesh：

Year:  2014        PMID： 24857082     DOI： 10.14694/EdBook_AM.2014.34.244

Source DB:  PubMed          Journal:  Am Soc Clin Oncol Educ Book        ISSN： 1548-8748


  9 in total

1.  Feasibility and clinical value of CT-guided 125I brachytherapy for metastatic soft tissue sarcoma after first-line chemotherapy failure.

Authors:  Zhiqiang Mo; Tao Zhang; Yanling Zhang; Zhanwang Xiang; Huzhen Yan; Zhihui Zhong; Fei Gao; Fujun Zhang
Journal:  Eur Radiol       Date:  2017-09-27       Impact factor: 5.315

2.  Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?

Authors:  Jason Klein; Alex Ghasem; Samuel Huntley; Nathan Donaldson; Martin Keisch; Sheila Conway
Journal:  Clin Orthop Relat Res       Date:  2018-03       Impact factor: 4.176

Review 3.  INTERACTS (INTErventional Radiotherapy ACtive Teaching School) consensus conference on sarcoma interventional radiotherapy (brachytherapy) endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology).

Authors:  Luca Tagliaferri; Andrea Vavassori; Valentina Lancellotta; Vitaliana De Sanctis; Cristiana Vidali; Calogero Casà; Cynthia Aristei; Domenico Genovesi; Barbara Alicja Jereczek-Fossa; Alessio Giuseppe Morganti; György Kovács; Jose Luis Guinot; Agata Rembielak; Daniela Greto; Maria Antonietta Gambacorta; Vincenzo Valentini; Vittorio Donato; Renzo Corvò; Stefano Maria Magrini; Lorenzo Livi
Journal:  J Contemp Brachytherapy       Date:  2020-08-21

4.  Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature.

Authors:  Zaixiang Tang; Qinghua Zeng; Yan Li; Xinyan Zhang; Mark J Suto; Bo Xu; Nengjun Yi
Journal:  Oncol Rep       Date:  2017-09-25       Impact factor: 3.906

5.  Development of a radiosensitivity gene signature for patients with soft tissue sarcoma.

Authors:  Zaixiang Tang; Qinghua Zeng; Yan Li; Xinyan Zhang; Jinlu Ma; Mark J Suto; Bo Xu; Nengjun Yi
Journal:  Oncotarget       Date:  2017-04-18

6.  The Role of Radiotherapy in Soft Tissue Sarcoma on Extremities With Lymph Nodes Metastasis: An IPTW Propensity Score Analysis of the SEER Database.

Authors:  Xinzhu Qiu; Hongbo He; Hao Zeng; Xiaopeng Tong; Qing Liu
Journal:  Front Oncol       Date:  2021-10-21       Impact factor: 6.244

7.  Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea-A Sarcoma-Specific, Institutional Registry-Based Analysis.

Authors:  Hyehyun Jeong; Hyeon-Su Im; Jeong Eun Kim; Jin-Hee Ahn; Wanlim Kim; Jong-Seok Lee; Si Yeol Song; Joon Seon Song; Kyung-Ja Cho; Hye Won Chung; Min Hee Lee
Journal:  Cancer Manag Res       Date:  2021-11-24       Impact factor: 3.989

8.  Associations of chemo- and radio-resistant phenotypes with the gap junction, adhesion and extracellular matrix in a three-dimensional culture model of soft sarcoma.

Authors:  Chujie Bai; Min Yang; Zhengfu Fan; Shu Li; Tian Gao; Zhiwei Fang
Journal:  J Exp Clin Cancer Res       Date:  2015-06-10

Review 9.  Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents.

Authors:  Cameron M Callaghan; M M Hasibuzzaman; Samuel N Rodman; Jessica E Goetz; Kranti A Mapuskar; Michael S Petronek; Emily J Steinbach; Benjamin J Miller; Casey F Pulliam; Mitchell C Coleman; Varun V Monga; Mohammed M Milhem; Douglas R Spitz; Bryan G Allen
Journal:  Cancers (Basel)       Date:  2020-08-12       Impact factor: 6.639
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.